Kinetics of the establishment of HIV-1 viral interference and comprehensive analysis of the contribution of viral genes  by Remion, Azaria et al.




E-mjournal homepage: www.elsevier.com/locate/yviroKinetics of the establishment of HIV-1 viral interference
and comprehensive analysis of the contribution of viral genes
Azaria Remion a,b,c, Marc Delord b,c, Allan J. Hance a,b,c,
Sentob Saragosti a,b,c, Fabrizio Mammano a,b,c,n
a INSERM, U941, Paris, France
b Univ Paris Diderot, Sorbonne Paris Cité, Paris, France
c Institut Universitaire d’Hématologie, Hôpital Saint-Louis, Paris, Francea r t i c l e i n f o
Article history:
Received 9 June 2015
Returned to author for revisions
1 July 2015
Accepted 26 September 2015





22/& 2015 Elsevier Inc. All rights reserved.
espondence to: Inserm U-941, Institut Unive
ayem Hôpital Saint-Louis, 1, Avenue Claude V
ail address: fabrizio.mammano@inserm.fr (F. Ma b s t r a c t
Viral interference deﬁnes the reduced susceptibility of an infected cell to reinfection. For HIV-1, both
receptor-dependent and independent pathways were described. The relative importance of different
receptor-independent pathways has not been addressed.
We have used reporter viruses to quantify the percentage of single- and double-infected cells, as a
function of the delay between the two infections. For co-infection experiments, the frequency of double
infected cells was higher than expected for independent events. By delaying the second infection, this
frequency progressively diminished, resulting in signiﬁcant interference after 18 h. Interference mea-
sured here was largely receptor-independent. By individually deleting viral genes or expressing them in
isolation, we demonstrate that the viral protein Rev plays a dominant role, while other viral proteins
contributes to optimal interference.
Our study deﬁnes the kinetics of early HIV-1 interference, describing the transition from higher
susceptibility to double-infection to viral interference, and identiﬁes Rev as its dominant effector.
& 2015 Elsevier Inc. All rights reserved.Introduction
Infection of a single cell by two HIV-1 virions allows genetic
recombination, an important evolutionary strategy that generates
chimeric genomes whose adaptation to the environment may
greatly exceed that of each parental genome (Burke, 1997).
Recombination requires the infection of a single cell by distinct
viruses, the subsequent incorporation of two different genomes
into a single virus particle, and template switching during reverse
transcription following the infection of a new target cell (reviewed
in Burke, 1997). Double-infection of target cells by HIV-1 in tissue
culture occurs more frequently than would be predicted if the two
infectious events were independent phenomena (Dang et al.,
2004). There is also direct evidence of the presence of multiple
HIV-1 genomes in cells obtained from infected patients. Although
most infected circulating lymphocytes carry only one copy of viral
genome, double-infected cells have been consistently detected
(Josefsson et al., 2011, 2013). Also, the epidemiologic spread of a
wide variety of circulating recombinant forms of HIV-1 (Allen andrsitaire d’Hématologie, Bâti-
ellefaux, 75010 Paris, France.
ammano).Altfeld, 2003) is a clear and relevant proof that double-infection
and recombination occur in infected patients.
Despite the advantages associated with double-infection, HIV-
1, as many other viruses, has evolved viral interference mechan-
isms to limit the occurrence of double-infections. It is assumed
that the purpose of these strategies is to prevent excessive viral
replication and premature cytolysis (Volsky et al., 1996). Mod-
ulating cell susceptibility to infection over time may allow HIV-1
to proﬁt from double-infection when it can lead to functional
recombination, and avoid its negative effects if the second virus
reaches a cell fully engaged in HIV-1 production. The kinetics of
the transition from susceptibility to interference has not been
precisely characterized.
Several distinct interference pathways have been described for
HIV-1, and the expression of six of the nine viral genes has been
proposed to participate in viral interference. A common mechan-
ism of interference for different virus families consists in the
occupation or down-modulation of the receptor by newly syn-
thesized viral proteins produced by the ﬁrst virus infection (Potash
and Volsky, 1998). Three HIV proteins (Env, Vpu and Nef) con-
tribute to the reduction of CD4 expression at the cell surface by
different mechanisms (Chen et al., 1996; Wildum et al., 2006). Env
and Vpu interfere with CD4 transport to the plasma membrane;
Nef induces the internalization of CD4 molecules that had already
Fig. 1. Frequency of double-infected cells following co-infection and super-infection at 24 h. The 3 upper panels show the distribution of cells in different FACS quadrants in
the following control conditions: left-no infection; center-infection by the virus expressing HSA; right-infection by the virus expressing GFP. The 2 lower panels show the
distribution of cells in different quadrants following co-infection (lower left panel) and super-infection at 24 h (lower right panel). The number of cells in each quadrant of
the 5 FACS plots is indicated in table. The OR of cells expressing both reporter genes (double-infection), was calculated by (B/A)/(D/C), as in (2). The distribution expected if
the two infectious events were independent would result in an OR of 1. ORs above 1 indicate that double-infections are favored, and ORs below 1 indicate inhibition of
double-infections, as expected in case of viral interference.
A. Remion et al. / Virology 487 (2016) 59–6760reached the cell surface. The physiological role of CD4 down-
modulation in HIV-1 infection, however, does not seem to be the
prevention of super-infection. Rather, it ensures efﬁcient Env
incorporation into budding virions, leading to increased infectivity
(Argañaraz et al., 2003). Also, it was recently shown that CD4
down-regulation by Nef and Vpu promotes escape from antibody-
dependent cell-mediated cytotoxicity (Pham et al., 2014). Similar
to the effect mediated by modulation of CD4 expression, inter-
ference in HIV-1 may also result from down-modulation of the
expression of the co-receptors CCR5 and CXCR4 by Nef (Venzke
et al., 2006; Michel et al., 2005).
Receptor/co-receptor-independent viral interference has also
been described for HIV-1, but the viral genes and mechanismsinvolved are not fully understood, as reviewed in Potash and Volsky
(1998) and Nethe et al. (2005). Volsky et al. (1996) reported viral
interference in the ﬁrst 24 hours post-infection, before detecting
any sign of CD4 down-modulation in infected cells. They excluded a
role for Vpu, Vpr and Nef, because a mutant virus defective for the
expression of these proteins displayed wild type level of inter-
ference (Volsky et al., 1996). Federico et al. (1995) reported that cells
chronically infected with a HIV-1 mutant that did not produce
infectious virus particles were resistant to super-infection through a
CD4-independent mechanism. This team went on to express indi-
vidual viral proteins of the mutant virus by transfection of HIV-1
susceptible cells, and provided evidence that the viral proteins Gag,
Vif and Nef contributed to the CD4-independent viral interference
A. Remion et al. / Virology 487 (2016) 59–67 61observed in the original report, whereas expression of Tat, Rev or
Vpu facilitated secondary infection (D’Aloja et al., 1998). In contrast
to this ﬁnding, the viral protein Rev was reported to promote viral
interference in HIV-1-infected cells by Levin et al. (2010). Overall,
these reports support the existence of receptor-independent viral
interference in HIV-1, but in these studies only the potential
implication of subsets of genes was investigated. As a consequence,
the relative importance of different viral genes in receptor-
independent HIV-1 interference has not been established.
Here, using isogenic reporter viruses, we precisely quantiﬁed
the frequency of single- and double-infected cells, as a function of
the interval between the two infection events (from 0 to 24 h). We
conﬁrm the higher than random frequency of double-infected cells
when cells are simultaneously exposed to the two viruses. By
increasing the time between the infections, the frequency of
double infected cells progressively decreased, reaching values
below those expected for independent events, starting at 18 h
post-infection. Using HIV-1 virions pseudotyped by the
amphotropic-MLV (A-MLV) envelope glycoproteins, we show that
viral interference was largely independent from receptor and co-
receptor mediated mechanisms. By individually deleting or
expressing viral genes in a sequential infection setting, we identify
Rev as the key viral effector of the interference measured here,
although other viral genes participate in the establishment of
optimal interference.Fig. 2. Frequency of double-infected cells as a function of the time that separates
the two infectious events. (A) The OR of double-infected cells is shown for co-
infections (exposure to both viruses at time 0) and for super-infections, in which
exposure to the second virus was delayed by 3, 6, 12, 18 and 24 h. Both the initial
and the super-infecting virus carry the HIV-1 Env. The bar graph represents the
mean and SEM from 12 experiments (6 in which the ﬁrst infection was performed
using the GFP virus, and 6 in which initial infection was performed with the HSA
virus). *** indicates po0.0001 as compared to the frequency observed for t¼0.
(B) CD4-independent viral interference. Experiments were conducted as in A,
except that the second infection was performed using an HIV-1 particle pseudo-
typed by the A-MLV Env. ORs of double-infections is shown for infections by A-MLV
pseudotyped virus taking place at time 0, 6, 12, 18 and 24 h after initial infection by
HIV-1. Data shown represent the mean and SEM (n¼4). *po0.05 as compared to
the frequency observed for t¼0. At 24 h the p value was 0.07.Results
Frequency of double-infected cells following co-infection
or super-infection at 24 h
We have used two HIV-1 proviral clones each expressing a
reporter protein, either green ﬂuorescent protein (GFP) or heat-
stable antigen (HSA), allowing quantiﬁcation of the cells infected
by one, the other, or both viruses. For this study, it was important
to use isogenic viral clones expressing all viral proteins, and dif-
fering only by the reporter gene. In the pNL4-3-derived plasmids
used here (Imbeault et al., 2009; Levy et al., 2004), sequences
coding the two reporter proteins were introduced before the nef
gene along with an IRES sequence, allowing concomitant expres-
sion of the viral and reporter proteins. To prevent virus spread in
culture, we deleted the env gene from the proviral constructs.
These Env-deﬁcient mutants were co-transfected with a plasmid
that allows HIV-1 Env expression in trans, and produced virus
particles competent for single cycle infection. Precluding virus
spread facilitates the study of the extent of super-infection as a
function of time, and eliminated the Env-mediated pathway of
CD4 down-modulation.
As shown in Fig. 1 (upper panels), infection by each virus could
be monitored by the distribution of cells into the four quadrants
(A, B, C, and D) of the FACS plot, following the expression of the
reporter genes (GFP or HSA). To compare the frequency of double
infected cells in the setting of co-infection (infection with two
different viruses added simultaneously) and super-infection at
24 h, cells in parallel wells were infected by both viruses or
infected only with either the GFP virus or the HSA virus. Cells were
washed 2 h post-infection. Wells infected by a single virus were
exposed to the other virus 24 h after the initial infection. The
results of a representative experiment comparing co-infections
(t¼0) and super-infections at 24 h are shown in Fig. 1 (lower
panels). From the distribution of the cell populations into the
quadrants of the FACS plot, we measured the frequency of double-
infected cells and compared it to the expected frequency if the two
events were independent, by calculating the odds ratio (OR) as
previously described (2). Brieﬂy, the number of cells in eachquadrant was used to calculate the ratio [B/(BþA)]/{1[B/
(BþA)]}, which upon simpliﬁcation becomes (B/A)/(D/C). If the
two infections are independent events, the ratio should be equal to
1. An OR41 indicates that double-infections occurred more fre-
quently than expected for independent events, and an ORo1
corresponds to lower frequency.
In the illustrated experiment, co-infection resulted in an OR of
2.47, indicating that the frequency of cells carrying the two
reporter genes is approximately 2.5-fold higher than expected for
independent events. The OR of co-infection was signiﬁcantly dif-
ferent from 1 using a Pearson's χ2 test (po0.0001). The higher
A. Remion et al. / Virology 487 (2016) 59–6762frequency of double-infections in the settings of co-infection has
been previously described (Dang et al., 2004). In striking contrast,
in the same experiment, delaying the second infection by 24 h
resulted in an OR of 0.46, indicating that the observed frequency of
double-infection is the half of what would be expected for inde-
pendent events (po0.0001), thus showing potent viral inter-
ference, particularly as compared to the frequency observed in the
co-infection conditions. These results conﬁrm prior studies, which
separately showed high frequency of double-infection at t¼0, and
interference at t¼24 h.
Dynamics of viral interference in HIV-1 infection
We next compared the OR of double-infections as a function of
the time between the initial infection and super-infection (3 h, 6 h,
12 h, 18 h or 24 h) (Fig. 2A). This analysis shows that the frequency
of double-infected cells gradually diminished as the interval
between initial infection and super-infection events increased. The
OR values remained above 1 for super-infection taking place in the
ﬁrst 12 h post-initial infection. Signiﬁcant viral interference, with
OR lower than 1, was measured starting at 18 h and it further
increased at 24 h post-initial infection.
Receptor-independent viral interference
We next determined the proportion of interference that was
not due to receptor and co-receptor down-modulation. We repe-
ated studies evaluating the kinetics of super-infection, but using
for the second infection virus particles pseudotyped with the A-
MLV Env glycoproteins, whose entry does not depend on CD4 and
chemokine receptors. The OR of co-infection using viruses carrying
these different Env proteins was still higher than 1, but did not
reach the same level as observed for HIV-1/HIV-1 co-infections
(Fig. 2B). As in the previous set of experiments, viral interference
(ORo1) was observed at 18 and 24 h post-initial infection. The
potency of interference is lower than that observed in experiments
in which the second virus also carried the HIV-1 Env proteins,
suggesting that CD4 and/or co-receptor down-modulation con-
tributes to, but does not fully account for, a major proportion of
the viral interference observed in Fig. 2A.
Role of viral genes in the establishment of HIV-1 viral interference
We next showed that the expression of viral genes is required
to induce viral interference. Indeed, initial infection performed
with HIV-1 particles carrying a lentiviral vector (LV) that expresses
only GFP (pLenti-GFP) did not induce signiﬁcant interference with
the infection by a wild-type virus (expressing HSA) added 18 h or
24 h post-initial infection (Fig. 3A, sample LV). In this situation, the
OR of double-infected cells remained above 1 at these late time
points, although it decreased as compared to the co-infection
context. Thus, completion of the early phases of HIV-1 replication
does not induce interference if it does not lead to viral protein
expression; rather, cells targeted by the ﬁrst virus remain pre-
ferential targets for the second infection at late time points.
To begin to evaluate the role of speciﬁc viral proteins in the
interference with HIV-1 super-infection, we performed similar
experiments to those detailed above, but using for the initial
infection viruses that are defective for a single viral gene. In these
studies, infected cells were exposed 18 h and 24 h later to wild-
type HIV-1 virus (Fig. 3A) or to A-MLV-pseudotyped HIV-1-parti-
cles (Fig. 3B), permitting evaluation of both receptor-dependent
and receptor-independent mechanisms. Loss of interference in
cells initially infected by a mutant virus would suggest the parti-
cipation of the missing viral protein to viral interference. Viral
clones individually defective for each accessory gene (vif, vpr, vpuand nef) were evaluated. As shown in Fig. 3A, all clones still
induced HIV-1 interference at 18 and 24 h post-initial infection,
indicating that no single accessory gene is responsible for inter-
ference. The same conclusion could be drawn when A-MLV-
pseudotyped virions were used for super-infection (Fig. 3B).
To study the potential involvement of the expression of the
remaining viral genes gag, pol, tat and rev in HIV-1 interference (all
experiments were performed in an env-defective context), a dif-
ferent strategy was required, because: i) preventing the expression
of tat and/or rev would indirectly abolish the expression of several
additional viral proteins in the infected cells, and ii) the production
of infectious virus particles after the abrogation of gag or pol
expression requires complementation. Thus, lentiviral vectors
were produced by co-transfection of a Gag-Pol-expressor plasmid,
an Env-expressor plasmid and a transfer vector carrying the
packaging signal. We constructed transfer vectors that allow the
expression in target cells only of Tat (Tþ), Tat and Rev (TþRþ), or
all viral proteins except Gag-Pol and Env (ΔGagPol). As shown in
Fig. 4A, cells initially infected by the vector encoding all proteins
except Gag-Pol and Env displayed an interference proﬁle similar to
the one observed with the virus defective only for Env expression
(WT), demonstrating that expression of Gag-Pol in infected cells is
not required for interference. The expression of Tat alone did not
interfere with the second infection, resulting in a proﬁle similar to
that observed for empty (GFP-only) lentiviral particles. In contrast,
the expression of both Tat and Rev did result in viral interference
at 18 h and 24 h, reducing the OR below 1. These results show that
the expression of Rev (together with Tat, but not Tat alone) was
required to reduce the cellular susceptibility to super-infection. As
for the previous sets of data, we veriﬁed that this interference
proﬁle was largely independent of effects on the expression of
HIV-1 receptors, because the results obtained using A-MLV pseu-
dotyped HIV-1 virions as super-infecting particles gave a similar
proﬁle (Fig. 4B).
The potency of interference observed after infection with
viruses expressing only Tat and Rev, as measured by the OR, was
lower than that observed when wild-type virus was used for initial
infection. This suggests that although expression of Rev per se
induces signiﬁcant viral interference, the expression of other viral
proteins, many of which are Rev-dependent, is required for opti-
mal interference. From Fig. 3, however, it appears that the deletion
of single accessory genes did not prevent the establishment of
interference. Altogether these results suggest that, in addition to
Rev, multiple genes participate in the interference phenotype, but
no single protein other than Rev plays a predominant role.Discussion
Cellular susceptibility to virus infection and to super-infection
depends on multiple parameters. Double-infection of target cells is
clearly advantageous for HIV-1 by fostering the genetic mixing of
viral genomes through recombination, but appears to be dis-
favored during later steps of infection by viral interference. This
study offers new insights into several aspects of this process,
including: i) the timing of the transition of HIV-1 infected cells
from a state of susceptibility to double-infections to that of resis-
tance, ii) the identiﬁcation of viral genes that contribute to the
inhibition of super-infection, and iii) the evaluation of the relative
importance of the receptor-dependent and receptor-independent
mechanisms implicated in viral interference.
Frequency of double infected cells during co-infection experiments
In our studies, the simultaneous exposure of cells to two dis-
tinct viral populations resulted in a higher frequency of double-
A. Remion et al. / Virology 487 (2016) 59–67 63infected cells than would be predicted for independent events. We
observed frequencies 2.5-fold higher than predicted for random
distribution, using two viruses pseudotyped by HIV-1 Env glyco-
proteins, while if one of the two viruses carried the A-MLV Env
complex, the frequency was somewhat lower (less than 2-fold).
Theses phenomena have been observed in previous studies, but
the mechanisms responsible have not been ﬁrmly established.
Two observations in our study provide additional information.
First, we found that the frequency of double infected-cells
remained higher than expected for independent events for up to
18–24 h, provided that the ﬁrst virus did not express viral proteins,
but only the reporter GFP protein (Fig. 3). Second, however, the
propensity for double-infection was always highest when the
viruses were added simultaneously, and then slowly decayed,
beginning at very early time points (3–6 h post-infection), before
any viral protein could be synthesized.
It has been proposed that the increased frequency of double-
infections was strictly a cellular phenomenon, reﬂecting the pre-
sence of distinct cell subpopulations that are more or less sus-
ceptible to infection (Dang et al., 2004). If this is the case, however,
our results indicate that the susceptible/resistant cell phenotype isFig. 3. Effect of the deletion of viral genes on the establishment of interference. (A) In
lentiviral vector expressing only GFP (LV), a series of viruses defective for the expression
0, 18 h or 24 h. The ORs of double-infections were calculated as described in Fig. 1 legend
(B) Experiments were conducted as in A, except that the second infection was performe
***po0.001, as compared to the frequency observed for t¼0.not stable and must evolve over time, but with kinetics that cannot
be attributed, for example, to a speciﬁc phase of the cell cycle.
Similarly, the viral entry pathway appears to modulate the pro-
pensity to double-infection, but the levels of expression of CD4
and/or co-receptors are unlikely to explain this, because the gra-
dual decay in the probability of double-infection was also seen for
cells super-infected by A-MLV pseudotyped viruses. It has also
been suggested that the disproportionate frequency of doubly-
infected cells during co-infection could result from increased
detection of otherwise silent infection events, triggered by the
additional Tat expression induced by the second virus (Bregnard
et al., 2012). In our experimental system, this potential artifact did
not play a role, since co-infection using lentiviral vectors that only
express GFP resulted in similarly high frequencies of double-
infected cells as those obtained using vectors that also encode
Tat (Fig. 3).
Our results support the existence of an alternative, non-
mutually exclusive mechanism, in which viral infection actively
promotes additional infectious events when the cell is simulta-
neously exposed to the two viruses, but the advantage would be
progressively reduced by increasing the time between the twoitial infection was performed using the indicated viruses: wild type HIV-1 (WT), a
of the indicated viral proteins (ΔX). Cells were then challenged by HIV-1 particles at
. Data shown represent the mean and SEM from at least 3 independent experiments.
d using an HIV-1 particle pseudotyped by the A-MLV Env. *po0.05, **po0.01, and
Fig. 4. Effect of the expression of viral proteins on the establishment of viral interference. (A) Initial infection was performed using the indicated viruses: wild type HIV-1
(WT), a lentiviral vector expressing GFP (LV), a vector expressing all HIV-1 proteins except Gag-Pol and Env (ΔGagPol), a vector expressing only Tat (Tþ), or Tat and Rev
(TþRþ). Cells were coinfected (t¼0) or superinfected 18 h or 24 h later by wild type HIV-1. The ORs of double-infections were calculated as described in Fig. 1 legend.
(B) Experiments were conducted as in A, except that the second infection was performed using an HIV-1 particle pseudotyped by the A-MLV Env. *po0.05, **po0.01, and
***po0.001, as compared to the frequency observed for t¼0.
A. Remion et al. / Virology 487 (2016) 59–6764infectious events. Among potential stimuli that might be expected
to follow such kinetics are cell signaling and activation induced by
Env-receptor interactions (Pace et al., 2011; Weissman et al., 1997),
virus-induced cortical actin depolymerization (Spear et al., 2012),
and/or saturation of antiviral factors by an increased number of
virions penetrating each cell (Neil and Bieniasz, 2009).
Viral interference
The high cell susceptibility to double-infection declined as the
intervals between the two infection events increased, and double-
infections become signiﬁcantly disfavored (with ORo1) 18 h and
24 h after initial infection. At these time points, several viral pro-
teins are expressed, and we clearly show here that expression of
Rev and Tat, but not Tat alone, is sufﬁcient for this active form of
interference. It is important to stress that while several HIV-1
genes were previously shown to participate in viral interference,
this is to our knowledge that the ﬁrst study in which all HIV-1genes were tested in parallel in the setting of successive virus
infections, allowing to identify Rev as a dominant effector of
receptor-independent interference.
Our results provide several insights into the mechanisms
through which Rev induces viral interference. First, throughout
our study, we compared the potency of interference using viruses
pseudotyped with the HIV-1 and A-MLV Env glycoproteins for the
second infection. The extent of interference appeared generally
less potent using A-MLV, indicating the possible participation of
receptor-mediated interference when using HIV-1 pseudotypes.
The patterns of interference, however, were very similar for HIV-1
and A-MLV pseudotypes; in both cases active interference began
18 h post-infection, and the results of experiments evaluating the
role of viral gene expression were indistinguishable in both set-
tings. These results demonstrate that the Rev-induced inter-
ference, and the overall interference observed within the ﬁrst 24 h
post-infection, are both largely independent of HIV-1 receptor/co-
receptor modulation.
A. Remion et al. / Virology 487 (2016) 59–67 65Second, the comparison of the interference induced after
infection by the Rev-encoding vector and by the wild type HIV-1
(Fig. 4A) shows that optimal interference required the expression
of other viral genes, in agreement with previous reports (Volsky
et al., 1996; Potash and Volsky, 1998; Venzke et al., 2006; Michel
et al., 2005; Nethe et al., 2005; Federico et al., 1995; D’Aloja et al.,
1998). Most viral genes require Tat and Rev to be expressed.
Abrogating the expression of individual accessory genes did not
prevent the induction of robust interference at 18–24 h (Fig. 3).
Altogether these results suggest that multiple genes contribute in
inducing optimal interference, but that no single accessory protein
plays a predominant role. Several viral genes have been previously
proposed to participate to receptor-independent HIV-1 inter-
ference (Volsky et al., 1996; D’Aloja et al., 1998; Levin et al., 2010),
and based on our results, expression of individual genes by viral
vectors competent for Tat and Rev expression, could allow the
determination of their relative potency.
Third, our observation that Rev triggers viral interference even
in the absence of other viral proteins (with the exception of Tat,
whose expression was necessary to induce the reporter gene)
shows that interference does not require the interaction of Rev
with viral proteins expressed following the initial infection. Two
possible pathways would be compatible with this observation.
First, Rev could interact with cellular factors in a way that
increases their ability to restrict the second infection. The HIV-1
Rev protein is indeed able to interact with several cellular ele-
ments, and accomplishes different functions in the nucleus and
cytoplasm of the infected cell, beyond its original role in viral RNA
export (Blissenbach et al., 2010; Pollard and Malim, 1998; HCT
et al., 2009). Alternatively, Rev could directly bind elements of the
second virus and prevent their function. This pathway was sug-
gested in the previous report describing a role for Rev in inter-
ference (Levin et al., 2010). The authors showed that Rev expres-
sion from an integration defective virus led to reduced integration
of a super-infecting virus (Levin et al., 2010). Based on previous
work from this group, describing an interaction between Rev and
integrase that can inhibit integration (Rosenbluh et al., 2007; Levin
et al., 2009), the authors suggested that the Rev protein expressed
by the ﬁrst virus might directly intercept and disable the viral
integrase of the superinfecting virus (Levin et al., 2010). The report
also conﬁrmed the existence of other mechanisms causing viral
interference, but the relative importance of Rev, as compared to
other HIV-1 genes, was not explored (Levin et al., 2010).
Of note, in the study by Levin et al. (2010) viral interference was
established with faster kinetics than in our analyses. Indeed, the
efﬁciency of second infections was reduced by 90% within 8 h from
the ﬁrst infection, a time at which the authors could detect Rev
expression from the non-integrated genomes following the ﬁrst
virus infection. In our study, interference could not be detected
until 18 h post-infection, a time at which Rev would be pre-
dominantly expressed from the integrated genomes. This suggests
that at least the source of Rev-expression was different in the two
studies. The difference in the kinetics could be due to the amount
of virus used. In Levin et al. the MOI ranged from 1 to 10, infecting
virtually all cells in the culture with both viruses, while we
ensured that a majority of uninfected targets cells were available
for the second infection, to preserve an unbiased distribution of
the viruses. Rev-mediated viral interference may conceivably
result from more than one mechanism, in which different levels of
Rev expression could drive either direct or cell-factor mediated
inhibition of the superinfecting virus. Further studies on the
mechanisms by which Rev induces viral interference may provide
additional insights on the capacity of HIV-1 to hijack cellular fac-
tors necessary for optimal infectivity.
The results described here show that co-infection is favored
early after an initial infection by HIV-1, while potent viralinterference is established 18–24 h post-infection. Interference
requires the expression of viral genes and, using an unbiased
approach, we show that Rev is the dominant factor for this phe-
notype. Rev-induced interference appears to be largely indepen-
dent of effects on the expression of HIV-1 receptors/co-receptors.
Optimal efﬁcacy of viral interference also requires the expression
of accessory genes, none of which, individually, plays a
predominant role.Methods
Cells and proviral plasmids
HEK293T cells were maintained in Dulbecco modiﬁed Eagle's
medium (DMEM) supplemented with 10% heat-inactivated fetal
calf serum (FCS) and antibiotics (100 IU/ml penicillin and 100 μg/
ml streptomycin). MT4R5 cells (Amara et al., 2003) were grown in
RPMI-1640 medium supplemented with 10% heat-inactivated FCS,
100 IU/ml of penicillin, 100 mg/ml of streptomycin and 0.25 μg/ml
of amphotericin B. All cultures were maintained at 37 °C in a
humidiﬁed atmosphere with 5% CO2.
The proviral constructs used here were derived from previously
published plasmids based on the pNL4-3 construct, and carrying
sequence coding either for GFP or HSA reporter proteins cloned
before the nef gene, with an IRES sequence allowing concomitant
expression of the viral and reporter proteins (Imbeault et al., 2009;
Levy et al., 2004). To prevent virus spread in culture, we have
modiﬁed these constructs by deleting 1.3 kb of the env gene
(between the KpnI and BglII sites). The expression of the individual
accessory genes was abolished in different proviral constructs
inserting previously described mutations. These mutations consist
either in large deletions in the 50 region of the gene: vif (deletion
nt 5128-5303, according to pNL4-3 numbering) (Cao et al., 2005),
vpu (deletion nt 6065-6112) (Schubert et al., 1995), vpr (deletion nt
5622-5742) (Bouhamdan et al., 1996); or in a frameshift induced
by ﬁlling-in the XhoI site at position 8887 in the nef gene
(Schwartz et al., 1995). To complement these proviral constructs
we used an HIV-1 Env-expressor plasmid, in which HIV-1 (pNL4-3)
Env, Tat and Rev expression is under the control of a chimeric SRα
promoter (SV40-early promoter, and LTR from HTLV-I), or a pre-
viously described A-MLV Env expressor plasmid pSV-A-MLV
(Landau et al., 1991).
To study the effect of Tat, Rev and Gag-Pol on viral interference,
we produced lentiviral vectors by cotransfection of a Gag-Pol-
expressor plasmid (R8.74, from Addgene), the HIV-1 Env-expressor
plasmid and a transfer vector (carrying the packaging signal). As
transfer vector we used a previously described pNL4-3 derivative
in which the expression of most viral genes was prevented,
allowing the expression in target cells only of Tat and Rev (TþRþ)
(Sakai et al., 2006). By introducing a stop codon at position 5983
(Sadaie et al., 1988) by site-directed mutagenesis in this plasmid,
we obtained a transfer vector that would only express Tat. We also
constructed a transfer vector that expresses all viral proteins
except Gag-Pol (ΔGagPol) by deleting the fragment between the
two SwaI sites in NL4-3. Finally, as a negative control, we used a
vector expressing only GFP under the CMV early promoter (pLenti-
GFP, from ABM Inc.).
Preparation of virus stocks and infection
Virus stocks were prepared by transfecting sub-conﬂuent 293-T
cells (in T75 ﬂasks) by JetPei (Polyplus transfection), following the
manufacturer's instructions. Medium was changed 16 h later, and
the virus-containing supernatant was collected 40 h post-trans-
fection, overlaid on a 20% sucrose cushion in a Beckman SW28
A. Remion et al. / Virology 487 (2016) 59–6766tube, and particles were pelleted by centrifugation (50,000 g;
4 °C) for 90 min. Viral pellets were resuspended in RPMI medium
with FCS to obtain a 10-fold concentration as compared to the
initial production in the culture supernatant, separated into sev-
eral aliquots and frozen at 80 °C. To evaluate the frequency of
infection, it was important to infect sufﬁcient cells to provide a
signal permitting precise quantiﬁcation, but to avoid infecting so
many cells with the ﬁrst virus that infection of cells with only the
second virus would be disfavored. To accomplish this, we infected
cells with serial 2-fold dilutions of virus, but excluded all results in
which the proportion of cells infected with the ﬁrst virus was
either o10% or 440%. If in one experiment more than one virus
input resulted in the appropriate percentage of infected cells
(between 10% and 40%) the individual OR values (see below) were
calculated and the mean value was used in the compilation of
results.
For each experiment, 2105 MT4R5 cells in parallel wells of
the same 96-well plate were “co-infected” (two viruses at the
same time) or infected by the ﬁrst virus (e.g. expressing HSA) and
then “super-infected” by the second virus (expressing GFP) at
different time points from 0 to 24 h. Two hours after infection
(both for initial infection and super-infection), cells were washed
to eliminate excess virus. For each time point analyzed here, cells
were seeded in a single plate, so that both co-infected and super-
infected cells underwent the same treatment.
Expression of the two marker proteins was followed over time
by collecting fractions of the cells infected by viruses competent
only for single cycle infection. The percentage of GFP-positive cells
was measured after cell ﬁxation with 2% PFA. HSA expression on
the surface of infected cells was detected using a rat anti-HSA
PerpCy5.5 antibody (Pharmagen) before ﬁxation in PFA. Flow-
cytometry data were acquired using a FACSCalibur instrument
(Becton Dickinson) with CellQuest software, and analyzed using
FlowJo software (Treestar). FACS analysis was performed to
determine the kinetics of expression of the reporter proteins,
which reached a plateau 48 h post-infection (data not shown). Cell
viability was measured in parallel, and found to be stable for at
least 72 h post-infection (data not shown). We veriﬁed that the
kinetics of induction of viral interference were independent of the
order of infecting viruses (i.e., GFP followed by HSA vs. HSA fol-
lowed by GFP) (data not shown).
Frequency of double infected cells
The frequency of double infected cells were quantiﬁed by cal-
culating the odds ratios (O.R.) as previously described (Dang et al.,
2004). Brieﬂy, according to the expression of GFP and/or HSA, cells
can be divided in the FACS graph into four quadrants A, B, C, and D
in Fig. 1. Cells in quadrant A express HSA, those in B are positive
both for HSA and GFP (double-infected cells), cells in quadrant C
are uninfected, while cells in D are GFP positive. We calculated the
distribution of the two infection events in the cell population to
determine if they were independent (OR¼1), or if double-
infection occurred more frequently (OR41) or less frequently
(ORo1) than expected for independent events. The number of
cells in each quadrant was obtained by multiplying the percentage
of cells in that quadrant by the total number of cells analyzed, and
was used to calculate the ratio [B/(BþA)]/{1[B/(BþA)]}, which
upon simpliﬁcation becomes (B/A)/(D/C). Pearson's χ2 test (using
GraphPad PrismVersion 6) was used to determine whether the OR
was signiﬁcantly different from 1. To compare the OR of co-
infection and super-infection at different time points, statistical
signiﬁcance was assessed by Kruskal–Wallis test (using GraphPad
PrismVersion 6). Post-test comparisons (performed only if
po0.05) were made using Dunn's Multiple Comparisons test.Acknowledgments
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